Sofiva Genomics Co.,Ltd.
6615.TWO
Price:
$29.85
Market Cap:
$644.56M
Sofiva Genomics Co.,Ltd. provides genetic testing services in Taiwan and internationally. The company offers prenatal services, including thalassemia carrier screening; tests for microdeletion syndromes and single-gene abnormalities; detection of common chromosome abnormalities, selected microdeletions syndromes, and selected skeletal dysplasia genetic mutations; multiple genetic diseases detection; folate metabolism genetic screening; spinal muscular atrophy carrier screening; fragile X syndrome carrier screening; congenital infection screening; risk assessment for early/late-onset preeclampsia; maternal serum screening for down syndrome; and karyotyping. It also provides cancer services, s...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-01-06
Stock Exchange
TWO
Ticker
6615.TWO
PE Ratio
[-63.51]
ROE
[-1.13%]
Current Ratio
[2.90]
Dividend Yield
[1.01%]
Enterprise Value
[609.02M]
Dividend History
The ROE as of December 2025 (TTM) for Sofiva Genomics Co.,Ltd. (6615.TWO) is -1.13%
According to Sofiva Genomics Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -1.13%. This represents a change of 298.54% compared to the average of -0.28% of the last 4 quarters.
Sofiva Genomics Co.,Ltd. (6615.TWO) Historical ROE (quarterly & annually)
How has 6615.TWO ROE performed in the past?
The mean historical ROE of Sofiva Genomics Co.,Ltd. over the last ten years is 4.49%. The current -1.13% ROE has changed -125.27% with respect to the historical average. Over the past ten years (40 quarters), 6615.TWO's ROE was at its highest in in the March 2024 quarter at 2.00%. The ROE was at its lowest in in the December 2024 quarter at -0.83%.
Average
4.49%
Median
4.56%
Minimum
0%
Maximum
9.13%
Sofiva Genomics Co.,Ltd. (6615.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Sofiva Genomics Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 9.13%
Minimum Annual Increase = -72.67%
Minimum Annual ROE = 0%
| Year | ROE | Change |
|---|---|---|
| 2024 | 2.86% | 53.46% |
| 2023 | 1.86% | -72.67% |
| 2022 | 6.82% | -25.24% |
| 2021 | 9.13% | 45.63% |
| 2020 | 6.27% | Infinity% |
Sofiva Genomics Co.,Ltd. (6615.TWO) Average ROE
How has 6615.TWO ROE performed in the past?
The current ROE of Sofiva Genomics Co.,Ltd. (6615.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.85%
5-year avg
5.39%
10-year avg
4.49%
Sofiva Genomics Co.,Ltd. (6615.TWO) ROE vs. Peers
How is 6615.TWO’s ROE compared to its peers?
Sofiva Genomics Co.,Ltd.’s ROE is less than Bioray Biotech Co., Ltd (7.09%), greater than TFBS Bioscience Inc. (-4.90%), greater than Original BioMedicals Co., Ltd. (-37.93%), greater than TaiwanJ Pharmaceuticals Co., Ltd. (-28.55%), greater than Health & Life Co., Ltd. (-3.67%), greater than Vectorite Biomedical Inc. (-5.93%), less than EBM Technologies Incorporated (3.92%), less than Welgene Biotech Co.,Ltd. (0.80%), greater than Sunder Biomedical Tech. Co., Ltd. (-1.35%), greater than AmCad BioMed Corporation (-10.14%),
| Company | ROE | Market cap |
|---|---|---|
| 7.09% | $606.50M | |
| -4.90% | $751.21M | |
| -37.93% | $938.89M | |
| -28.55% | $641.78M | |
| -3.67% | $530.97M | |
| -5.93% | $612.80M | |
| 3.92% | $683.20M | |
| 0.80% | $438.12M | |
| -1.35% | $514.20M | |
| -10.14% | $968.99M |
Build a custom stock screener for Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sofiva Genomics Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Sofiva Genomics Co.,Ltd. (6615.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Sofiva Genomics Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Sofiva Genomics Co.,Ltd.'s ROE?
How is the ROE calculated for Sofiva Genomics Co.,Ltd. (6615.TWO)?
What is the highest ROE for Sofiva Genomics Co.,Ltd. (6615.TWO)?
What is the 3-year average ROE for Sofiva Genomics Co.,Ltd. (6615.TWO)?
What is the 5-year average ROE for Sofiva Genomics Co.,Ltd. (6615.TWO)?
How does the current ROE for Sofiva Genomics Co.,Ltd. (6615.TWO) compare to its historical average?